U.S. Department of Health and Human Services
Staff Search  

If you plan to apply, Register Early.

Registration is required at eRA Commons and grants.gov and can take 4 weeks.​

End-Stage Renal Disease

The End-Stage Renal Disease (ESRD) program promotes basic, translational, and clinical research to reduce morbidity and mortality from kidney failure or ESRD and to improve the effectiveness of dialysis and transplantation.  The portfolio includes studies on factors associated with fistula maturation, complications of grafts for vascular access, appropriate dialysis dose, and infectious complications in peritoneal dialysis.  Studies also are promoted on the causes and prevention of progressive loss of kidney function in long-term kidney transplant recipients.​​​​​​​​​​​​​​​​​

 

 NIDDK Staff

 
Kevin Abbott, M.D., M.P.H.Kidney and Urology EpidemiologyMichael Flessner, M.D., Ph.D.Clinical CKD; Glomerular Disease; Clinical PKD; PKD CentersPaul L. Kimmel, M.D.Clinical AKI; Kidney Translational Genetics; Kidney Centers; Kidney HIV/AIDS
John W. Kusek, Ph.D.Kidney and Urology Clinical TrialsAndrew Narva, M.D.​Kidney Translation; Director, National Kidney Disease Education Program (NKDEP) Krystyna Rys-Sikora, Ph.D.Basic AKI and CKD

 

 Related Funding Opportunities

 
Posted DateTitleFull Announcement
11/14/2014Administrative Supplements for Research on Sex/Gender Differences (Admin Supp) (Summary) PA-15-034
10/3/2014Innovative Research in HIV in Kidney, Urology and Hematology (R01) (Summary) RFA-DK-14-020
9/2/2014(Re)Building a Kidney Coordinating Center (U01) (Summary) RFA-DK-14-009
9/2/2014(Re)Building a Kidney: Cells to Organ (UH2/UH3) (Summary) RFA-DK-14-010
7/30/2014NIDDK Central Repositories Non-renewable Sample Access (X01) (Summary) PAR-14-301
View More Funding Opportunities

The resources listed below include reagents, data, protocols, etc. If you would like to utilize any of these resources, contact the person associated with the resource.

 

 Research Resources

 
Resource NameDescription
Action to Control Cardiovascular Disease Risk in Diabetes Follow-up Study
ACCORDION (sponsored by NHLBI) is a prospective, observational follow-up study of at least 8000 participants who were treated and followed in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.  Treatment in ACCORD ended in 2009 and…
Diabetic Complications Consortium
The goal of the NIDDK-sponsored Diabetic Complications Consortium (DiaComp) is to foster communication and collaboration between investigator communities involved in complications research.  Toward this goal, DiaComp: (1) sponsors annual meetings in…
Rare Kidney Stone Consortium

The Consortium facilitates cooperative exchange of information and resources among investigators, clinicians, patients, and researchers in order to improve care and outcomes for patients with rare stone diseases.  The consortium promotes ready…

Randomized Intervention for Children with Vesicoureteral Reflux

The purpose of this study is to learn whether all children with vesicoureteral reflux (VUR) should be treated with antibiotics. The study will tell us if prophylactic antibiotic treatment prevents urinary tract infections and renal scarring in…

United States Renal Data System

The United States Renal Data System (USRDS) is a national data system that collects, analyzes, and distributes information about end-stage renal disease (ESRD) in the United States. The USRDS is funded directly by the National Institute of Diabetes…

View Additional Research Resources

 

 NIDDK Active Trials in Kidney Disease

 
View related clinical trials from ClinicalTrials.gov.

 

 Related Study Sections

 
​​Study sections conduct initial peer review of applications in a designated scientific area. View related study sections from the NIH's Center for Scientific Review.